Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07VYX
|
||||
Former ID |
DNC007295
|
||||
Drug Name |
4-((+/-)-(1H-imidazol-1-yl)-(E)-methylretinoate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527351] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H32N2O2
|
||||
Canonical SMILES |
CC1=C(C(CCC1N2C=CN=C2)(C)C)C=CC(=CC=CC(=CC(=O)OC)C)C
|
||||
InChI |
1S/C24H32N2O2/c1-18(8-7-9-19(2)16-23(27)28-6)10-11-21-20(3)22(12-13-24(21,4)5)26-15-14-25-17-26/h7-11,14-17,22H,12-13H2,1-6H3/b9-7+,11-10+,18-8+,19-16+
|
||||
InChIKey |
LEOKNFOQHCUMCU-PFLBVIONSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 26 | Target Info | Inhibitor | [527351] | |
KEGG Pathway | Retinol metabolism | ||||
Metabolic pathways | |||||
PathWhiz Pathway | Retinol Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.